Mallinckrodt News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mallinckrodt Plc MNK NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.05 -2.01% 2.44 2.435 2.63 2.54 2.49 16:03:15
more quote information »

Recent News

Date Time Source Heading
7/07/202009:26PRNUSMallinckrodt Confirms that U.S. Food and Drug Administration..
6/17/202006:45PRNUSMallinckrodt to Present at the BMO Prescriptions for Success..
6/15/202011:35EDGARCurrent Report Filing (8-k)
6/15/202010:50PRNUSMallinckrodt to Proceed with Appeal Despite Appellate Court..
6/15/202006:30PRNUSMallinckrodt to Present Phase 3 StrataGraft® Regenerative..
6/11/202006:45PRNUSReal-World Data of Terlipressin in Hospitalized Patients in..
6/09/202006:32PRNUSMallinckrodt Completes Rolling Submission of Biologics..
6/01/202006:45PRNUSMallinckrodt Will Appeal District Court Ruling in Case..
5/28/202016:23EDGARSpecialized Disclosure Report (sd)
5/15/202017:01EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:55EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:51EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:50EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:40EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:37EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:28EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:26EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:15EDGARStatement of Changes in Beneficial Ownership (4)
5/14/202016:02EDGARCurrent Report Filing (8-k)
5/07/202016:44EDGARAmended Statement of Ownership (sc 13g/a)
5/06/202016:13EDGARQuarterly Report (10-q)
5/05/202006:50EDGARCurrent Report Filing (8-k)
5/05/202006:45PRNUSMallinckrodt plc Reports Earnings for the First Quarter 2020..
5/04/202006:45PRNUSMallinckrodt Announces Positive Findings in INOmax® (Nitric..
4/30/202016:02EDGARCurrent Report Filing (8-k)
4/30/202008:04PRNUSMallinckrodt Supports Investigator-Initiated Study at..
4/22/202006:45PRNUSMallinckrodt Announces U.S. Food and Drug Administration..
4/21/202017:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/16/202006:45PRNUSMallinckrodt to Report Earnings Results for First Quarter..
4/15/202016:03EDGARCurrent Report Filing (8-k)
4/15/202006:45PRNUSMallinckrodt Announces Publication of Data on Acthar® Gel..
4/07/202008:59EDGARCurrent Report Filing (8-k)
4/06/202006:45PRNUSMallinckrodt Initiates Rolling Submission of Biologics..
4/03/202017:05EDGARStatement of Changes in Beneficial Ownership (4)
4/03/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
4/03/202016:46EDGARStatement of Changes in Beneficial Ownership (4)
4/03/202016:42EDGARStatement of Changes in Beneficial Ownership (4)
4/03/202016:29EDGARStatement of Changes in Beneficial Ownership (4)
4/03/202016:20EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202016:11EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/02/202016:06EDGARProxy Statement (definitive) (def 14a)
4/01/202006:45PRNUSMallinckrodt and Novoteris Receive Clearance from Health..
3/18/202013:11EDGARCurrent Report Filing (8-k)
3/17/202006:45PRNUSMallinckrodt Completes Rolling Submission of New Drug..
3/16/202006:00PRNUSMallinckrodt Confirms Court Decision in Lawsuit Against U.S...
3/12/202006:45PRNUSMallinckrodt Evaluates the Potential Role for Inhaled Nitric..
3/12/202006:32EDGARCurrent Report Filing (8-k)
3/11/202006:07EDGARCurrent Report Filing (8-k)
3/11/202006:00PRNUSMallinckrodt Provides Update on Proposed Global Opioid..
3/06/202017:00EDGARStatement of Ownership (sc 13g)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.